Novakand Pharma enters Letter of Intent with SVF Vaccines regarding a reverse takeover
Novakand Pharma has entered into a non-binding letter of intent with SVF Vaccines for a reverse takeover. The Transaction is subject to approvals from Extraordinary General Meetings in both Novakand and SVF and Nasdaq’s approval of the combined company for continued listing.